Redeye updates its estimates and valuation following Navigo releasing its Q3 2024 report. The report missed our estimates, with a potential market recovery for subsidiaries coming later than we originally pencilled in. Still, we judge demand and profitability should improve markedly in Q4 2024e and return to pre-recession levels in 2025e amidst a broader economic recovery. We lower our estimates and valuation.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/